Viking Therapeutics (VKTX) Misses Q1 EPS by 35c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($1.37), $0.35 worse than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Subaru, other Japan suppliers to team on delivery as Boeing raises output - Nikkei
• John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
• Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c